Cross-validation of the Depression, Anxiety, and Positive Outlook Scale (DAPOS) for Clinical Use

Olaya‐Contreras, Patricia; Styf, Jorma; Lundberg, Mari; Jansson, Bengt

doi:10.1097/ajp.0b013e318202131b

Cited by 3 publications

(1 citation statement)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…At study visits 2 to 6, we administered the following questionnaires to capture the secondary outcome measures for chronic pain: brief pain inventory, 1 , 38 Insomnia Severity Index (ISI), 2 Pain Disability Index, 37 and Depression, Anxiety, and Positive Outlook Scale. 26 The Neuropathic Pain Symptom Inventory and QST on the affected area were used to assess the neuropathic characteristics of the pain. 5 , 32 Quantitative sensory testing punctate pain threshold was taken as the mean of the weight at which pain is felt when a set of 7 standardized punctate probes (8–512 mN in weight) were applied in ascending and descending series.…”

Section: Methodsmentioning

confidence: 99%

Role of hyperpolarization-activated cyclic nucleotide-gated ion channels in neuropathic pain: a proof-of-concept study of ivabradine in patients with chronic peripheral neuropathic pain

Healey

Scholtes

Abrahams

et al. 2021

PR9

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 99%

Role of hyperpolarization-activated cyclic nucleotide-gated ion channels in neuropathic pain: a proof-of-concept study of ivabradine in patients with chronic peripheral neuropathic pain

Healey

Scholtes

Abrahams

et al. 2021

PR9

View full text Add to dashboard Cite

show abstract

Pain Management and ROM Desensitization

Lederman

2014

Therapeutic Stretching

View full text Add to dashboard Cite

Baseline measures for women with mesh complications accessing a pain service (as part of the London Complex Mesh Centre)

Thillainathan,

Cambitizi,

Tidman

et al. 2023

British Journal of Pain

View full text Add to dashboard Cite

Introduction Pelvic mesh was first used for stress urinary incontinence in 1998 following which its usage rapidly expanded to include treatment of pelvic organ prolapse. Numerous complications relating to mesh insertion soon became apparent, culminating in the Independent Medicines and Medical Devices Safety: First Do No Harm Report published by Baroness Cumberlege in 2020. Following this report, the UCLH London Complex Mesh Centre funded by NHS England, was one of a small number of specialist centres set up for mesh-injured women. The Pelvic Pain service of the Pain Management Centre at UCLH provides a service for patients attending the London Complex Mesh Centre. The aim of our study was to distinguish the differing needs of mesh-injured women from those with chronic pelvic pain by comparing patient-reported outcome measures between these two cohorts. Methods Distribution of data was calculated using the D’Agostino–Pearson normality test. Mann–Whitney tests were used to ascertain statistical difference between the two cohorts. Ethnicity was compared between groups using Fisher’s exact test. Quantile regression models were used to assess whether differences in medians between groups remained after adjustment for age and ethnicity. Statistical significance was set at p < .05. Results Patients with mesh were significantly older than those with chronic pelvic pain and were more likely to be of white ethnicity. After adjustment for age and ethnicity, analysis revealed that bladder interference, sex interference and DAPOS A were significantly higher amongst mesh-injured women, whereas GP and hospital admissions were significantly lower. Discussion Our data shows the importance of mesh-injured women having access to pain management services with pathways of care integrated within women’s and mental health services. It is essential that these programmes include support to discuss ways of returning to sexual relationships and have models to address anxiety such as graded exposure and psychological input.

show abstract

Cross-validation of the Depression, Anxiety, and Positive Outlook Scale (DAPOS) for Clinical Use

Cited by 3 publications

References 36 publications

Role of hyperpolarization-activated cyclic nucleotide-gated ion channels in neuropathic pain: a proof-of-concept study of ivabradine in patients with chronic peripheral neuropathic pain

Role of hyperpolarization-activated cyclic nucleotide-gated ion channels in neuropathic pain: a proof-of-concept study of ivabradine in patients with chronic peripheral neuropathic pain

Pain Management and ROM Desensitization

Baseline measures for women with mesh complications accessing a pain service (as part of the London Complex Mesh Centre)

Contact Info

Product

Resources

About